Midnolin is a novel regulator of parkin expression and is associated with Parkinson’s Disease
Yutaro Obara(Yamagata University), Kuniaki Ishii(Yamagata University)
Cited by 36
Related Papers
Mutations in the <i>SLC34A2</i> Gene are Associated with Pulmonary Alveolar Microlithiasis
|American Journal of Respiratory and Critical Care Medicine|2006|196
The voltage‐dependent K<sup>+</sup> channel (Kv1.5) cloned from rabbit heart and facilitation of inactivation of the delayed rectifier current by the rat β subunit
|FEBS Letters|1995|22
Endocytic Regulation of Voltage-Dependent Potassium Channels in the Heart
|Journal of Pharmacological Sciences|2012|17
ERK5 Phosphorylates Kv4.2 and Inhibits Inactivation of the A-Type Current in PC12 Cells
|International Journal of Molecular Sciences|2018|8
Midnolin, a Genetic Risk Factor for Parkinson’s Disease, Promotes Neurite Outgrowth Accompanied by Early Growth Response 1 Activation in PC12 Cells
|Molecular and Cellular Biology|2024|8